2216. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Linda L Humphrey.;Nick Fitterman.;Melissa Starkey.;Paul Shekelle.; .
来源: Ann Intern Med. 2013年159卷11期770-779页
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the treatment of anemia and iron deficiency in adult patients with heart disease.
2217. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI).
2218. Treatment of anemia in patients with heart disease: a systematic review.
作者: Devan Kansagara.;Edward Dyer.;Honora Englander.;Rongwei Fu.;Michele Freeman.;David Kagen.
来源: Ann Intern Med. 2013年159卷11期746-757页
The benefits of anemia treatment in patients with heart disease are uncertain.
2219. Examination of links between herpes zoster incidence and childhood varicella vaccination.
作者: Craig M Hales.;Rafael Harpaz.;M Riduan Joesoef.;Stephanie R Bialek.
来源: Ann Intern Med. 2013年159卷11期739-45页
Introduction of a universal varicella vaccine program for U.S. children in 1996 sparked concern that less-frequent exposure to varicella would decrease external boosting of immunity to varicella zoster virus and thereby increase incidence of herpes zoster (HZ).
2220. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
作者: Chen-Hua Liu.;Chung-Feng Huang.;Chun-Jen Liu.;Chia-Yen Dai.;Cheng-Chao Liang.;Jee-Fu Huang.;Peir-Haur Hung.;Hung-Bin Tsai.;Meng-Kun Tsai.;Shih-I Chen.;Jou-Wei Lin.;Sheng-Shun Yang.;Tung-Hung Su.;Hung-Chih Yang.;Pei-Jer Chen.;Ding-Shinn Chen.;Wan-Long Chuang.;Ming-Lung Yu.;Jia-Horng Kao.
来源: Ann Intern Med. 2013年159卷11期729-38页
Data are limited on the efficacy and safety of pegylated interferon plus ribavirin for patients with hepatitis C virus genotype 1 (HCV-1) receiving hemodialysis.
|